Hypertension Among Cohort of Persons With Human Immunodeficiency Virus Initiated on a Dolutegravir-Based Antiretroviral Regimen in Ghana
Authors:
Open Access
- 5 February 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (3) , ofae061
Abstract
Background: Dolutegravir (DTG), a new antiretroviral drug, is being integrated into antiretroviral regimens for people with human immunodeficiency virus (PWH) in Ghana. There is little evidence of the effect of DTG on blood pressure (BP) levels in sub-Saharan Africa, especially West Africa. Our aim was to assess the incidence and predictors of hypertension (HTN) among PWH initiated on a DTG-based antiretroviral regimen in Ghana. Methods: An observational multicenter longitudinal study was conducted among PWH in Ghana from 2020 to 2022. BPs of nonhypertensive patients with BP ≤120/80 mm Hg at baseline were measured at 3, 6, 12, and 18 months post–DTG initiation. The primary outcome of the study was incidence of HTN, defined as BP ≥140/90 mm Hg. Kaplan-Meier estimator was used to estimate risk of developing HTN. Cox proportional hazards model with robust standard errors was used to estimate hazard ratios (HRs). Results: HTN prevalence among PWH screened was 37.3% (1366/3664). The incidence of de novo HTN among nonhypertensive PWH at 72 weeks was 598.4 per 1000 person-years (PY) (95% confidence interval [CI], 559.2–640.3) with incidence proportion of 59.90 (95% CI, 57.30–62.44). A quarter of those with de novo HTN developed it by month 6. Obesity (adjusted HR [aHR], 1.27 [95% CI, 1.05–1.54]), abnormal serum urea (aHR, 1.53 [95% CI, 1.27–1.85]), and low high-density lipoprotein (aHR, 1.45 [95% CI, 1.22–1.72]) were risk factors for HTN. Conclusions: Incidence of HTN was high among PWH on DTG. There is a need to monitor BP for HTN in adult PWH as well as traditional risk factors to reduce the burden of HTN and its complications.Keywords
This publication has 38 references indexed in Scilit:
- Blood Pressure Measurement Challenges in Severely Obese PatientsAmerican Journal of Hypertension, 2018
- Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South AfricaPLOS ONE, 2018
- Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIVCirculation, 2018
- Aging, non-communicable diseases, and old-age disability in low- and middle-income countries: a challenge for global healthInternational Journal of Public Health, 2018
- Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure GuidelineJACC, 2018
- Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysisJournal of the American Society of Hypertension, 2017
- Low level of extra-pair paternity between nearest neighbors results from female preference for high-quality males in the yellow-rumped flycatcher (Ficedula zanthopygia)PLOS ONE, 2017
- Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysisJournal of Human Hypertension, 2015
- Gender Differences in Hypertension and Hypertension Awareness Among Young AdultsBiodemography and Social Biology, 2015
- Equipment errors: A prevalent cause for fallacy in blood pressure recording - A point prevalence estimate from an indian health universityIndian Journal of Community Medicine, 2013